» Articles » PMID: 32440605

Hippocampal Volume in Psychiatric Diagnoses: Should Psychiatry Biomarker Research Account for Comorbidities?

Overview
Publisher Sage Publications
Specialty Psychiatry
Date 2020 May 23
PMID 32440605
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Many research papers claim that patients with specific psychiatric disorders (major depressive disorder, posttraumatic stress disorder, borderline personality disorder, alcohol use disorder, and others) have smaller hippocampi, but most of those reports compared patients to healthy controls. We hypothesized that if psychiatrically matched controls (psychiatric control, matched for demographics and psychiatric comorbidities) were used, much of the biomarker literature in psychiatric research would not replicate. We used hippocampus and amygdala volume only as examples, as these are very commonly replicated results in psychiatry biomarker research. We propose that psychiatry biomarker research could benefit from using psychiatric controls, as the use of healthy controls results in data that are not disorder-specific.

Method: Hippocampus/amygdala volumes were compared between major depressive disorder, sex-/age-/race-matched healthy control, and psychiatric control (N = 126/group). Similar comparisons were performed for posttraumatic stress disorder (N = 67), borderline personality disorder (N = 111), and alcohol use disorder (N = 136).

Results: Major depressive disorder patients had smaller left (p = 8.79 × 10) and right (p = 3.13 × 10) hippocampal volumes than healthy control. Posttraumatic stress disorder had smaller left (p = 0.018) and right (p = 8.64 × 10) hippocampi than healthy control. Borderline personality disorder had smaller right hippocampus (p = 7.90 × 10) and amygdala (p = 1.49 × 10) than healthy control. Alcohol use disorder had smaller right hippocampus (p = 0.034) and amygdala (p = .024) than healthy control. No differences were found between any of the four diagnostic groups and psychiatric control.

Conclusion: When psychiatric controls were used, there was no difference in hippocampal or amygdalar volume between any of the diagnoses studied and controls. This strategy (keeping all possible relevant variables matched between experimental groups) has been used to advance science for hundreds of years, and we propose should also be used in biomarker psychiatry research.

Citing Articles

The Association between Dietary Protein Intake and Sources and the Rate of Longitudinal Changes in Brain Structure.

Cui F, Li H, Cao Y, Wang W, Zhang D Nutrients. 2024; 16(9).

PMID: 38732531 PMC: 11085529. DOI: 10.3390/nu16091284.


Inflammation and emotion regulation: a narrative review of evidence and mechanisms in emotion dysregulation disorders.

Petruso F, Giff A, Milano B, De Rossi M, Saccaro L Neuronal Signal. 2023; 7(4):NS20220077.

PMID: 38026703 PMC: 10653990. DOI: 10.1042/NS20220077.


miR-124-3p target genes identify globus pallidus role in suicide ideation recovery in borderline personality disorder.

Aloi M, Poblete G, Oldham J, Patriquin M, Nielsen D, Kosten T Npj Ment Health Res. 2023; 2(1):8.

PMID: 37712050 PMC: 10500603. DOI: 10.1038/s44184-023-00027-w.


Habenular molecular targets for depression, impulsivity, and addiction.

Srivastava S, Arenkiel B, Salas R Expert Opin Ther Targets. 2023; 27(9):757-761.

PMID: 37705488 PMC: 10591939. DOI: 10.1080/14728222.2023.2257390.


Cross-sectional field study comparing hippocampal subfields in patients with post-traumatic stress disorder, major depressive disorder, post-traumatic stress disorder with comorbid major depressive disorder, and adjustment disorder using routine....

Knaust T, Siebler M, Tarnogorski D, Skiberowski P, Hollmer H, Moritz C Front Psychol. 2023; 14:1123079.

PMID: 37384185 PMC: 10299169. DOI: 10.3389/fpsyg.2023.1123079.


References
1.
Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

2.
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine D, Quinn K . Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010; 167(7):748-51. DOI: 10.1176/appi.ajp.2010.09091379. View

3.
Le Berre A, Rauchs G, La Joie R, Mezenge F, Boudehent C, Vabret F . Impaired decision-making and brain shrinkage in alcoholism. Eur Psychiatry. 2012; 29(3):125-33. DOI: 10.1016/j.eurpsy.2012.10.002. View

4.
Zetzsche T, Preuss U, Frodl T, Schmitt G, Seifert D, Munchhausen E . Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder. Psychiatry Res. 2007; 154(2):157-70. DOI: 10.1016/j.pscychresns.2006.05.010. View

5.
Soloff P, Pruitt P, Sharma M, Radwan J, White R, Diwadkar V . Structural brain abnormalities and suicidal behavior in borderline personality disorder. J Psychiatr Res. 2012; 46(4):516-25. PMC: 3307855. DOI: 10.1016/j.jpsychires.2012.01.003. View